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A series of benzylidene hydrazides (1e20) was synthesized and tested, in vitro, for antibacterial, anti-
fungal and antiviral activities. The microbial screening results indicated that compounds having chloro
and nitro substituents were the most active ones. The antiviral evaluation depicted that compounds 9
and 19 were active against Vesicular stomatitis virus (VSV) in HeLa cell cultures. QSAR investigations
indicated that the multi-target QSAR model was effective in describing the antimicrobial (antibacterial
and antifungal) activity over the one-target QSAR models. Further the mt-QSAR model indicated that the
topological parameters, second order molecular connectivity index (2c) and third order Kier’s alpha
shape index (ka3) are effective in describing the antimicrobial activity of synthesized hydrazides.
 2010 Elsevier Masson SAS. All rights reserved.1. Introduction
Recently infectious diseases have dramatically increased and
become a major threat to public health, despite tremendous
progress in medicinal chemistry. The impact is more acute in
developing countries due to non availability of desired medicines
and emergence of widespread drug resistance [1]. Infections caused
by fungal species are common in immunocompromised patients
and carry significant treatment cost and mortality [2]. Antibacterial
resistance is a growing problemwhich necessitates the discovery of
newer antibiotics with activity against resistant strains [3].
Hydrazide derivatives have been claimed to possess antimicro-
bial [4], antimycobacterial [5], antitumour [6], anti-inflammatory
[7], trypanocidal [8], antimalarial [9] and anti-HIV activities [10].
Quantitative structure activity relationship (QSAR), one of the
most important area in medicinal chemistry, gives information that
is useful for drug design. QSAR models are mathematical equations
relating chemical structure to a wide variety of physical, chemical
and biological properties. The derived relationship between
molecular descriptors and activity is used to estimate the property: þ91 1262 274133.
imhan).
son SAS. All rights reserved.of other molecules and/or to find the parameters affecting the
biological activity [11].
Diseases caused by herpesviruses play an important role in viral
infections of humans especially the incidence of infections by
herpes simplex virus (HSV) is high throughout the world. Clinical
manifestations of diseases due to HSV range from mucosal ulcer-
ations with HSV-1 (Herpes labialis) to ulcerating vesicular lesions
with HSV-2 (Herpes genitalis). More rarely, HSV infections can result
in keratoconjunctivitis, eczema herpeticatum, herpes encephalitis,
generalized disseminated diseases in neonates and immunosup-
pressed patients [12]. Vesicular stomatitis virus (VSV), a member of
the Rhabdoviridae family, is an enveloped single-stranded RNA
virus that causes an economically important disease in cattle,
horses and swine [13].
The alphaviruses are pathogenic viruses with worldwide
distribution. Infection can result in fever, rash, arthralgia or
arthritis, lassitude, headache and myalgia. The prototypic alphavi-
rus is Sindbis virus, which is transmitted to humans through
mosquito bites [14]. Respiratory syncytial virus (RSV), a para-
myxovirus, is an important cause of respiratory tract infection in
infants, young children and adults [15].
The enterovirus, Coxsackie virus B3 (CVB3) is considered to be
the most important etiological agent of virus-induced acute and
chronic myocarditis. Since, more than 65 enterovirus serotypes
D. Kumar et al. / European Journal of Medicinal Chemistry 45 (2010) 2806e2816 2807exist, it was not possible to generate a vaccine until now and
considerable interest exists to develop antiviral compounds. So far,
these virus infections are treated symptomatically because there
are no virus-specific prophylactics and drugs available for clinical
use [16].
Inspired by the above facts and in continuation of our ongoing
research program in the field of synthesis, antimicrobial activity
and QSAR studies of medicinally important compounds [17e26],
we hereby report the synthesis, antimicrobial activity, QSAR studies
and antiviral evaluation of benzylidene hydrazides.2. Chemistry
The synthesis of target compounds was carried out as depicted
in Schemes 1 and 2. The different carboxylic acids were refluxed
with ethanol in presence of sulphuric acid to yield their ethyl esters.
The ethyl ester was refluxed with hydrazine hydrate in ethanol to
yield the corresponding hydrazide which was then refluxed with
benzaldehyde/o-chlorobenzaldehyde to yield the target acid
hydrazones. The products were separated out by evaporating
ethanol and recrystallized from ethanol to yield the pure
compounds. The completion of reaction was monitored by single
spot TLC on Merck silica gel G plates. All the compounds were
obtained in appreciable yield and their physicochemical charac-
teristics are presented in Table 1.
The structures of the synthesized compounds (1e20) were
ascertained on the basis of their consistent IR and NMR spectralO
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Scheme 1. Synthetic route followed to obtain target compounds from aliphatic acids.characteristics. The presence of C]O functional group was marked
by theappearanceof stretchingbandaround1700cm1,which is the
characteristic of an amide linkage. The appearance of stretching
band around 3200 cm1 indicated the presence of NH linkage of
amide bond of hydrazone. The presence of peaks slightly above and
below 3000 cm1 indicated the presence of aromatic and aliphatic
portion in synthesized compounds respectively. The appearance of
aliphatic eC]Ce stretching band at 1658.5 cm1 in compound 5
indicates the presence of unsaturated sorbic acid moiety in its
structure. In compound 9, the ArOCH3 stretching at 1270.9 cm1
reveals the presence ofmethoxygroup of veratric acid. The aromatic
nitro stretching around 1350 cm1 (symmetric NO2 stretching) and
1540 cm1 (asymmetric NO2 stretching) depicts the presence of
nitro functional group in synthesized compounds 10 and 20. The
appearance of singlet signal ranging from d 8.10e10.47 ppm in
compounds 1e20 confirms the presence of NH of hydrazide. The
presence of aromatic hydrogens was confirmed by the multiplet
signal in the range of d 7.0e8.0 ppm. The appearance of triplet signal
at d 0.82e0.89 ppm in compounds 1 and 13 reveals the presence of
terminal methyl group. Further, in compound 9, singlet signal at
d 3.92 ppm depicted the presence of methoxy group.
3. Results and discussion
3.1. Antibacterial and antifungal activity
Benzylidene hydrazides [1e20] were evaluated for their in vitro
antibacterial activity against Gram-positive Staphylococcus aureus,
Bacillus subtilis, Gram-negative Escherichia coli and antifungal
activity against Candida albicans and Aspergillus niger by serial
dilution method [27] using ciprofloxacin and fluconazole as refer-
ence standards for antibacterial and antifungal activity respectively
and the results are presented in Table 2.
For antifungal activity against A. niger compounds 9, 10, 16 and
18 have shown marked antifungal potential having pMIC value
greater than 1.60 as compared to other synthesized derivatives. In
case of C. albicans compounds 4, 13, 19 and 20 were found to be
most active with pMIC value 2.09, 2.10, 2.01 and 2.05 respectively.
In case of S. aureus compounds 13 and 14 emerged as effective
antibacterial agent having pMIC value 1.50 and 1.53 respectively. In
case of E. coli compounds 4 and 11 have shown good antibacterial
capability at a pMIC value 1.79 and 1.80 respectively. For antibac-
terial activity against B. subtilis, compounds 4,13 and 14 had shown
good antibacterial potential with pMIC value of 1.49, 1.49 and 1.53
respectively. It can be seen from Table 2 that synthesized benzyli-
dene hydrazides have higher antifungal potential as compared to
their antibacterial activity.
The minimum bactericidal concentration/minimum fungicidal
concentration (MBC/MFC) (Table 3) determination results revealed
that the synthesized compounds were fungistatic against both
fungi and bacteriostatic against S. aureus, but bactericidal against
E. coli and B. subtilis. In general, the MBC and MFC of synthesized
benzylidene derivatives were 3-fold higher than the MIC values
which indicated that the synthesized compound were bacterio-
static and fungistatic in action except for B. subtilis and E. coli (a
drug is considered to be bacteriostatic/fungistatic when its MBC
and MFC values are 3-fold higher than its MIC values) [28]. In case
of B. subtilis compounds 13 and 14 and for E. coli compounds 11e13
were found to be active bactericidal agents.
3.2. QSAR studies
3.2.1. Development of one-target QSAR model
In order to understand the experimental antibacterial and
antifungal activity data of 20 substituted benzylidene derivatives
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Scheme 2. Synthetic route followed to obtain target compounds from aromatic acids.
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activity relationship (QSAR) between their in vitro activity and
descriptors coding for lipophilic, electronic, steric and topological
properties of the molecules under consideration using the linear
free energy relationship model (LFER) described by Hansch and
Fujita [11]. Biological activity data determined as MIC values
were first transformed into pMIC values and used as dependent
variable in QSAR study. The different molecular descriptors
(independent variables) like log of octanolewater partition
coefficient (log P), molar refractivity (MR), Kier’s molecular
connectivity (0c, 0cv, 1c, 1cv, 2c, 2cv) and shape (k1, ka1, ka2, ka3)
topological indices, Randic topological index (R), Balaban topo-
logical index (J), Wiener topological index (W), Total energy (Te),
energies of highest occupied molecular orbital (HOMO) and
lowest unoccupied molecular orbital (LUMO), dipole moment (m)
and electronic energy (Ele.E), calculated for benzylidene hydra-
zides are presented in Table 4 [29e34]. Units of the energies and
dipole were electron volts (eV), and atomic units (a.u.), respec-
tively [35].In the present study, a data set of 20 benzylidene hydrazide
derivatives was subjected to linear free energy regression analysis
for model generation. The reference drugs were not included in
model development as they belong to different structural series.
Preliminary analysis was carried out in terms of correlation anal-
ysis. A correlation matrix constructed for antibacterial activity
against S. aureus is presented in Table 5. The correlations of
different molecular descriptors with antibacterial and antifungal
activity are presented in Table 6. In general, high colinearity
(r > 0.8) was observed between different parameters. The high
interrelationship was observed between 0c and Ele.E (r ¼ 0.999),
and low interrelationship was observed between 1c and LUMO
(r ¼ 0.002). The correlation matrix indicated the predominance of
topological parameters in describing the antibacterial and anti-
fungal activity of synthesized compounds.
The antibacterial activity of synthesized benzylidene hydrazides
against S. aureus is explained by the topological parameter, zero
order molecular connectivity index (Eq. (1)).
QSAR model for antibacterial activity against S. aureus
Table 1
Physicochemical characteristics of synthesized benzylidene hydrazides.
Comp. Mol. formula M. wt. Mp/Bpþ (C) Rf % Yield
1 C19H30N2O 302 60e64 0.62 67.8
2 C21H34N2O 330 65e69 0.43 58.3
3 C23H38N2O 358 93e97 0.65 62.3
4 C25H42N2O 386 Semisolid 0.57 59.3
5 C13H14N2O 214 Semisolid 0.72a 45.1
6 C16H14N2O 250 92e96 0.76a 40.0
7 C15H14N2O 238 Semisolid 0.62a 79.0
8 C15H14N2O 238 220e224 0.82a 54.3
9 C16H16N2O3 284 228e232 0.83a 74.0
10 C 14H10N4O5 314 205e209 0.65a 78.3
11 C19H29N2OCl 336 63e67 0.71 40.0
12 C21H33N2OCl 364 69e73 0.73 84.0
13 C23H37N2OCl 392 98e102 0.72 63.0
14 C25H41N2OCl 420 108e112 0.78 22.3
15 C13H13N2OCl 248 170e174þ 0.71a 61.1
16 C16H13N2OCl 284 Semisolid 0.50a 80.2
17 C15H13N2OCl 272 155e159 0.75a 40.1
18 C15H13N2OCl 272 241e245þ 0.85a 42.2
19 C16H15N2O3Cl 318 240e244 0.88a 80.0
20 C14H9N4O5Cl 384 235e239 0.89a 58.0
Mobile phase e Toluene:Chloroform (7:3).
a Ethyl acetate:Hexane (6:4).
Table 3
MBC/MFC values of synthesized benzylidene hydrazides.
Comp. MBC/MFC (mM/mL)
S. aureus B. subtilis E. coli C. albicans A. niger
1 >0.166 >0.166 0.041 >0.166 >0.166
2 >0.152 >0.152 >0.152 >0.152 >0.152
3 >0.139 0.139 >0.139 >0.139 >0.139
4 0.129 <0.129 0.064 <0.129 0.03
5 >0.233 >0.233 0.058 >0.233 >0.233
6 >0.200 >0.200 0.050 >0.200 >0.200
7 >0.210 0.052 >0.210 >0.210 >0.210
8 >0.210 0.210 0.052 >0.210 >0.210
9 0.088 0.044 0.177 0.011 0.022
10 >0.159 0.159 >0.159 0.159 0.079
11 >0.148 0.148 0.009 >0.148 >0.148
12 >0.137 >0.137 0.034 >0.137 >0.137
13 >0.127 0.031 0.031 >0.127 >0.127
14 >0.119 0.029 >0.119 >0.119 0.059
15 >0.201 0.050 0.100 >0.201 >0.201
16 0.176 0.088 >0.176 >0.176 >0.176
17 >0.183 0.045 0.045 >0.183 >0.183
18 0.045 0.183 0.045 >0.183 0.183
19 >0.157 0.039 >0.157 0.019 >0.157
20 >0.130 0.065 >0.130 >0.130 >0.130
Std. 0.019 0.019 0.019 0.040 0.040
D. Kumar et al. / European Journal of Medicinal Chemistry 45 (2010) 2806e2816 2809pMICsa ¼ 0:0295 0cþ 0:918 (1)
n ¼ 20 r ¼ 0:981 q2 ¼ 0:953 s ¼ 0:017 F ¼ 448:25
Here and thereafter, n e number of data points, r e correlation
coefficient, q2 e cross-validated r2 obtained by leave one out
method, se standard error of the estimate and Fe Fischer statistics.
As the coefficient of 0c in Eq. (1) is positive, therefore the anti-
bacterial activity against S. aureus will increase with increase in
value of 0c. This is clearly evident from Table 4 that compounds 13
and 14 having high 0c values, 19.58 and 21.00 (Table 4), have
increased antibacterial activity values 1.50 and 1.53 (Table 2)
respectively. Similarly, compounds 5, 7 and 8 having minimum 0c
values 11.64, 12.79 and 12.79 (Table 4), have minimum antibacterial
activity against S. aureus (Table 2). Topological indices are numer-
ical quantifier of molecular topology and are sensitive to bondingTable 2
Antibacterial and antifungal potential (mM/mL) of synthesized benzylidene
hydrazides.
Comp. pMICsa pMICbs pMICec pMICca pMICan pMICb pMICf pMICam
1 1.38 1.30 1.38 1.21 1.21 1.35 1.21 1.30
2 1.42 1.42 1.36 1.24 1.24 1.40 1.24 1.34
3 1.46 1.46 1.50 1.76 0.86 1.47 1.31 1.41
4 1.49 1.49 1.79 2.09 1.20 1.59 1.65 1.61
5 1.23 1.23 1.23 0.93 1.54 1.23 1.24 1.23
6 1.30 1.30 1.30 1.90 1.60 1.30 1.75 1.48
7 1.28 1.28 1.28 1.88 1.58 1.28 1.73 1.46
8 1.28 1.28 1.28 1.34 1.88 1.28 1.61 1.41
9 1.36 1.36 1.36 1.96 1.66 1.36 1.81 1.54
10 1.40 1.40 1.40 1.70 1.70 1.40 1.70 1.52
11 1.43 1.43 1.80 1.73 1.43 1.55 1.58 1.56
12 1.47 1.47 1.47 1.12 1.12 1.47 1.12 1.33
13 1.50 1.49 1.50 2.10 1.27 1.50 1.69 1.57
14 1.53 1.53 1.53 1.83 1.29 1.53 1.56 1.54
15 1.30 1.30 1.30 1.60 1.50 1.30 1.55 1.40
16 1.36 1.36 1.36 1.76 1.76 1.36 1.76 1.52
17 1.34 1.34 1.34 1.34 1.51 1.34 1.43 1.37
18 1.34 1.34 1.34 1.61 1.61 1.34 1.61 1.45
19 1.41 1.41 1.41 2.01 1.56 1.41 1.79 1.56
20 1.45 1.45 1.45 2.05 1.60 1.45 1.83 1.60
S.D.c 0.08 0.08 0.15 0.35 0.25 0.10 0.22 0.11
Std. 2.61a 2.61a 2.61a 2.64b 2.64b 2.61 2.64 2.62
a Ciprofloxacin.
b Fluconazole.
c Standard deviation.pattern, symmetry, content of heteroatom as well as degree of
complexity of atomic neighborhoods [36]. The zero ordermolecular
connectivity index, 0c, represents the molecules with unbranched
structure.
The QSAR model expressed by Eq. (1) was cross-validated by its
high q2 values (q2 ¼ 0.953) obtained by leave one out (LOO)
method. The value of q2 greater than 0.5 is the basic requirement
for qualifying a QSARmodel to be valid one [37]. The comparison of
observed and predicted antibacterial activities is presented in Table
7. It can be seen from the results that the observed and predicted
antibacterial activities lie close to each other as evidenced by their
low residual values (Table 7).
Eqs. (2)e(5) were developed to predict the antibacterial and
antifungal activity of benzylidene hydrazides against B. subtilis,
E. coli, C. albicans and A. niger.
QSAR model for antibacterial activity against B. subtilis
pMICbs ¼ 0:000012 Ele:Eþ 1:084 (2)
n ¼ 20 r ¼ 0:956 q2 ¼ 0:905 s ¼ 0:026 F ¼ 189:66
QSAR model for antibacterial activity against E. coli
pMICec ¼ 0:025 ka1 þ 0:975 (3)
n ¼ 20 r ¼ 0:752 q2 ¼ 0:479 s ¼ 0:103 F ¼ 23:86
QSAR model for antifungal activity against C. albicans
pMICca ¼ 1:1372cþ 0:0474 (4)
n ¼ 20 r ¼ 0:511 q2 ¼ 0:054 s ¼ 0:308 F ¼ 6:36
QSAR model for antifungal activity against A. niger
pMICan ¼ 0:046 ka3 þ 1:832 (5)
n ¼ 20 r ¼ 0:863 q2 ¼ 0:680 s ¼ 0:129 F ¼ 52:30
In case of B. subtilis, the developed QSAR model indicated the
predominance of electronic energy in describing the antibacterial
activity. The coefficient of electronic energy (Ele.E) is negative,
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D. Kumar et al. / European Journal of Medicinal Chemistry 45 (2010) 2806e28162810which shows that the antibacterial activity will increase with the
decrease in electronic energy of the synthesized compound, which
can be clearly seen from the results of antibacterial activity against
B. subtilis (Table 2) and values of electronic energy presented in
Table 4.
For antibacterial activity against E. coli, the developed QSAR
model (Eq. (3)) describes the importance of Kier’s alpha shape
topological index (ka1). In this case, the positive correlation was
observed between ka3 and antibacterial activity against E. coli. The
model described by Eq. (4) depicted the importance of second order
molecular connectivity index, 2c, in describing the antifungal
activity against C. albicans.
The model described by Eq. (5) demonstrated the importance of
Kier’s alpha shape topological index (ka3) in describing the anti-
fungal activity against A. niger. The negative correlation of molec-
ular descriptor with antifungal activity reveals that decrease in
value of ka3 (Table 4) will lead to increase in antifungal activity
against A. niger. The low residual values presented in Table 7 are in
agreement with the models expressed by Eqs. (2)e(5).
As in case of Eq. (1), the high q2 values supported the validity of
developed QSARmodels described by Eqs. 2, 3 and 5. It is important
to note that Eqs. (2)e(5) were derived using the entire data set as
there were no outliers in the data set. Even though the sample size
and the ‘Rule of Thumb’ allowed us to go for development of tetra-
parametric model in multiple linear regression analysis, the high
colinearity [21] among the parameters restricted us to go for mono-
parametric model only. The ‘Rule of Thumb’ gives information
about the number of parameters to be selected for regression
analysis in QSAR based on the number of compounds [38].
According to this rule for QSAR model development one should
select one parameter for a five-compound data set.
Generally for QSAR studies, the biological activities of
compounds should span 2e3 orders of magnitude. But in the
present study the range of antibacterial and antifungal activities of
the synthesized compounds is within one order of magnitude. But
it is important to note that the predictability of the QSAR models
developed in the present study is high evidenced by their low
residual values. This is in accordance with results suggested by the
Bajaj et al. [39], who stated that the reliability of the QSAR model
lies in its predictive ability even though the activity data are in the
narrow range. Further, recent literature reveals that the QSAR have
been applied to describe the relationship between narrow range of
biological activity and physicochemical properties of the molecules
[24,40e42]. When biological activity data lies in the narrow range,
the presence of minimum standard deviation of the biological
activity justifies its use in QSAR studies [24,25]. The minimum
standard deviation (Table 2) observed in the antimicrobial activity
data justifies its use in QSAR studies. Some of the other statistically
important ot-QSAR models are given in Table 8.
3.2.2. Development of multi-target QSAR model
According to the above ot-QSAR models one should use five
different equations with different errors to predict the activity of
a new compound against the five microbial species. The ot-QSAR
models, which are almost in all the literature, become unpractical
or at less complicated to use when we have to predict to each
compound results for more than one target. In these cases we have
to develop one ot-QSAR for each target. However, very recently the
interest has been increased in development of multi-target QSAR
(mt-QSAR)models. In opposition to ot-QSAR, themt-QSARmodel is
a single equation that considers the nature of molecular descriptors
which are common and essential for describing the antibacterial
and antifungal activity [43e47].
In the present study we have attempted to develop three
different types of mt-QSAR models viz. mt-QSAR model for
Table 5
Correlation matrix for antibacterial activity of benzylidene hydrazides against S. aureus.
pMICsa log P 0c 0cv 1c 1cv 2c 2cv 3c 3cv ka1 ka2 ka3 Te Ele.E
pMICsa 1.000
log P 0.784 1.000
0c 0.923 0.822 1.000
0cv 0.899 0.940 0.950 1.000
1c 0.914 0.859 0.994 0.967 1.000
1cv 0.861 0.971 0.917 0.991 0.944 1.000
2c 0.864 0.636 0.941 0.808 0.916 0.749 1.000
2cv 0.881 0.968 0.929 0.993 0.951 0.994 0.787 1.000
3c 0.074 0.536 0.083 0.348 0.169 0.447 0.236 0.374 1.000
3cv 0.096 0.447 0.179 0.331 0.248 0.427 0.109 0.334 0.873 1.000
ka1 0.901 0.920 0.965 0.991 0.975 0.982 0.822 0.978 0.323 0.365 1.000
ka2 0.801 0.957 0.865 0.958 0.897 0.981 0.652 0.957 0.562 0.575 0.963 1.000
ka3 0.760 0.953 0.827 0.931 0.863 0.965 0.599 0.935 0.613 0.631 0.938 0.996 1.000
Te 0.890 0.646 0.958 0.837 0.924 0.773 0.973 0.799 0.183 0.041 0.865 0.702 0.649 1.000
Ele.E 0.925 0.823 0.999 0.954 0.993 0.920 0.936 0.932 0.091 0.180 0.967 0.867 0.827 0.956 1.000
Table 6
Correlation of molecular descriptors with antimicrobial (antibacterial and antifungal) activity.
Mol. descriptor pMICsa pMICbs pMICec pMICca pMICan pMICb pMICf pMICam
log P 0.796 0.757 0.681 0.097 0.796 0.784 0.369 0.129
MR 0.922 0.889 0.739 0.266 0.769 0.887 0.221 0.308
0c 0.981 0.955 0.740 0.381 0.655 0.923 0.066 0.455
0cv 0.935 0.900 0.750 0.260 0.769 0.899 0.225 0.311
1c 0.967 0.939 0.740 0.372 0.683 0.914 0.089 0.432
1cv 0.889 0.846 0.733 0.192 0.804 0.861 0.299 0.230
2c 0.939 0.933 0.657 0.511 0.430 0.864 0.162 0.609
2cv 0.913 0.874 0.742 0.222 0.773 0.881 0.258 0.274
3c 0.016 0.036 0.163 0.338 0.580 0.074 0.591 0.442
3cv 0.055 0.010 0.172 0.293 0.583 0.096 0.558 0.399
k1 0.953 0.918 0.749 0.288 0.745 0.908 0.189 0.346
k2 0.823 0.774 0.698 0.120 0.844 0.804 0.378 0.135
k3 0.765 0.711 0.668 0.058 0.860 0.754 0.435 0.061
ka1 0.939 0.900 0.752 0.244 0.778 0.901 0.243 0.298
ka2 0.818 0.768 0.699 0.103 0.850 0.801 0.394 0.120
ka3 0.770 0.716 0.674 0.055 0.863 0.760 0.439 0.060
R 0.967 0.939 0.740 0.372 0.683 0.914 0.089 0.432
J 0.320 0.273 0.348 0.300 0.589 0.342 0.564 0.276
W 0.906 0.881 0.720 0.296 0.732 0.871 0.176 0.334
Te 0.962 0.948 0.689 0.449 0.498 0.890 0.075 0.552
Ele.E 0.980 0.956 0.745 0.383 0.659 0.925 0.066 0.456
LUMO 0.090 0.131 0.019 0.270 0.386 0.055 0.429 0.381
HOMO 0.568 0.592 0.289 0.168 0.135 0.476 0.058 0.313
m 0.608 0.593 0.602 0.070 0.774 0.643 0.488 0.045
Table 7
Comparison of observed and predicted antibacterial and antifungal activity obtained by ot-QSAR model.
Comp. pMICsa (Eq. (1)) pMICbs (Eq. (2)) pMICec (Eq. (3)) pMICca (Eq. (4)) pMICan (Eq. (5))
Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res.
1 1.38 1.39 0.01 1.30 1.38 0.08 1.38 1.45 0.07 1.21 1.59 0.38 1.21 1.32 0.11
2 1.42 1.43 0.01 1.42 1.42 0.00 1.36 1.50 0.14 1.24 1.69 0.45 1.24 1.23 0.01
3 1.46 1.47 0.01 1.46 1.46 0.00 1.50 1.55 0.05 1.76 1.79 0.03 0.86 1.15 0.29
4 1.49 1.51 0.02 1.49 1.50 0.01 1.79 1.60 0.19 2.09 1.88 0.21 1.20 1.07 0.13
5 1.23 1.26 0.03 1.23 1.26 0.03 1.23 1.29 0.06 0.93 1.30 0.37 1.54 1.57 0.03
6 1.30 1.31 0.01 1.30 1.31 0.01 1.30 1.31 0.01 1.90 1.52 0.38 1.60 1.60 0.00
7 1.28 1.30 0.02 1.28 1.29 0.01 1.28 1.29 0.01 1.88 1.50 0.38 1.58 1.66 0.08
8 1.28 1.30 0.02 1.28 1.29 0.01 1.28 1.29 0.01 1.34 1.49 0.15 1.88 1.66 0.22
9 1.36 1.36 0.00 1.36 1.36 0.00 1.36 1.36 0.00 1.96 1.63 0.33 1.66 1.62 0.04
10 1.40 1.41 0.01 1.40 1.40 0.00 1.40 1.39 0.01 1.70 1.83 0.13 1.70 1.62 0.08
11 1.43 1.41 0.02 1.43 1.41 0.02 1.80 1.48 0.32 1.73 1.66 0.07 1.43 1.35 0.08
12 1.47 1.45 0.02 1.47 1.45 0.02 1.47 1.53 0.06 1.12 1.76 0.64 1.12 1.27 0.15
13 1.50 1.50 0.00 1.49 1.49 0.00 1.50 1.58 0.08 2.10 1.86 0.24 1.27 1.19 0.08
14 1.53 1.54 0.01 1.53 1.53 0.00 1.53 1.63 0.10 1.83 1.95 0.12 1.29 1.11 0.18
15 1.30 1.29 0.01 1.30 1.28 0.02 1.30 1.32 0.02 1.60 1.37 0.23 1.50 1.58 0.08
16 1.36 1.34 0.02 1.36 1.32 0.04 1.36 1.34 0.02 1.76 1.59 0.17 1.76 1.60 0.16
17 1.34 1.32 0.02 1.34 1.32 0.02 1.34 1.32 0.02 1.34 1.57 0.23 1.51 1.65 0.14
18 1.34 1.32 0.02 1.34 1.32 0.02 1.34 1.32 0.02 1.61 1.56 0.05 1.61 1.65 0.04
19 1.41 1.39 0.02 1.41 1.39 0.02 1.41 1.39 0.02 2.01 1.70 0.31 1.56 1.62 0.06
20 1.45 1.44 0.01 1.45 1.43 0.02 1.45 1.42 0.03 2.05 1.90 0.15 1.60 1.61 0.01
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Table 8
Regression analysis and quality of correlation for modeling antibacterial and antifungal activity of synthesized benzylidene hydrazides.
S. no. QSAR model (pMIC¼) n r q2 s F
S. aureus
1. 0.000012Ele.E þ 1.087 20 0.980 0.951 0.017 446.56
2. 0.0431c þ 0.927 20 0.967 0.919 0.022 258.85
3. 0.043R þ 0.927 20 0.967 0.919 0.022 258.85
4. 0.000011Te þ 0.962 20 0.962 0.909 0.023 225.84
B. subtilis
5. 0.02950c þ 0.918 20 0.955 0.906 0.026 185.42
6. 0.00011Te þ 0.956 20 0.948 0.886 0.028 159.12
7. 0.042R þ 0.927 20 0.939 0.858 0.030 133.33
8. 0.0421c þ 0.927 20 0.939 0.858 0.030 133.33
E. coli
9. 0.0370cv þ 0.928 20 0.750 0.463 0.103 23.13
10. 0.027k1 þ 0.901 20 0.749 0.474 0.104 22.94
11. 0.000017Ele.E þ 1.004 20 0.745 0.456 0.104 22.40
12. 0.0702cv þ 1.04 20 0.742 0.456 0.105 22.03
C. albicans
13. 0.00022Te þ 0.829 20 0.494 0.033 0.320 4.535
A. niger
14. 0.0370cv þ 0.928 20 0.750 0.463 0.103 23.13
15. 0.027k1 þ 0.901 20 0.749 0.474 0.104 22.94
16. 0.000017Ele.E þ 1.004 20 0.745 0.456 0.104 22.40
17. 0.0702cv þ 1.047 20 0.742 0.456 0.105 22.03
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S. aureus, B. subtilis and E. coli, mt-QSAR model for describing
antifungal activity of synthesized compounds against C. albicans
and A. niger as well a common mt-QSAR model for describing the
antimicrobial (overall antibacterial and antifungal) activity of
substituted benzylidene hydrazides against all the above
mentioned microorganisms.
In order to develop mt-QSAR models, initially we have
calculated the average antibacterial activity
[pMICb ¼ (pMICsa þ pMICbs þ pMICec)/3], antifungal activity
[pMICf ¼ (pMICca þ pMICan)/2] and antimicrobial activity values
[pMICam ¼ (pMICsa þ pMICbs þ pMICec þ pMICca þ pMICan)/5] of
substituted hydrazide derivatives which are presented in Table 2.
These average activity values were also correlated with the
molecular descriptors of synthesized compounds (Table 6).
The mt-QSAR model for antibacterial activity displayed the
importance of both electronic energy (r ¼ 0.925) and zero orderTable 9
Comparison of observed and predicted antimicrobial activity obtained by mt-QSAR mod
Comp. pMICb (Eq. (6)) pMICf (Eq. (8))
Obs. Pre. Res. Obs. Pre. Res.
1 1.35 1.39 0.04 1.21 1.43 0.22
2 1.40 1.44 0.04 1.24 1.43 0.19
3 1.47 1.49 0.02 1.31 1.43 0.12
4 1.59 1.53 0.06 1.65 1.43 0.22
5 1.23 1.25 0.02 1.24 1.43 0.19
6 1.30 1.32 0.02 1.75 1.50 0.25
7 1.28 1.29 0.01 1.73 1.57 0.16
8 1.28 1.29 0.01 1.61 1.57 0.04
9 1.36 1.37 0.01 1.81 1.62 0.19
10 1.40 1.42 0.02 1.70 1.83 0.13
11 1.55 1.43 0.12 1.58 1.50 0.08
12 1.47 1.48 0.01 1.12 1.50 0.38
13 1.50 1.52 0.02 1.69 1.50 0.19
14 1.53 1.57 0.04 1.56 1.50 0.06
15 1.30 1.28 0.02 1.55 1.50 0.05
16 1.36 1.33 0.03 1.76 1.57 0.19
17 1.34 1.32 0.02 1.43 1.64 0.21
18 1.34 1.32 0.02 1.61 1.64 0.03
19 1.41 1.40 0.01 1.79 1.69 0.10
20 1.45 1.45 0.00 1.83 1.90 0.07molecular connectivity index, c0 (r ¼ 0.923), in describing the
antibacterial activity of substituted benzylidene hydrazides, as the
value of correlation coefficients in developed models (Eqs. (6) and
(7)) is nearly same.
mt-QSAR model for antibacterial activity
pMICb ¼ 0:000014 Ele:Eþ 1:058 (6)
n ¼ 20 r ¼ 0:925 q2 ¼ 0:82 s ¼ 0:039 F ¼ 107:31
pMICb ¼ 0:0330cþ 0:870 (7)
n ¼ 20 r ¼ 0:923 q2 ¼ 0:811 s ¼ 0:039 F ¼ 103:59
The mt-QSAR model for antifungal activity revealed the
importance of third order molecular connectivity index (3c) in
describing antifungal activity.els.
pMICam (Eq. (9)) pMICam MLR (Eq. (10))
Obs. Pre. Res. Obs. Pre. Res.
1.30 1.44 0.14 1.30 1.39 0.09
1.34 1.47 0.13 1.34 1.42 0.08
1.41 1.51 0.10 1.41 1.46 0.05
1.61 1.54 0.07 1.61 1.49 0.12
1.23 1.33 0.10 1.23 1.29 0.06
1.48 1.41 0.07 1.48 1.42 0.06
1.46 1.40 0.06 1.46 1.42 0.04
1.41 1.40 0.01 1.41 1.42 0.01
1.54 1.45 0.09 1.54 1.48 0.06
1.52 1.52 0.00 1.52 1.59 0.07
1.56 1.46 0.10 1.56 1.44 0.12
1.33 1.50 0.17 1.33 1.47 0.14
1.57 1.53 0.04 1.57 1.50 0.07
1.54 1.57 0.03 1.54 1.54 0.00
1.40 1.36 0.04 1.40 1.34 0.06
1.52 1.44 0.08 1.52 1.46 0.06
1.37 1.43 0.06 1.37 1.46 0.09
1.45 1.43 0.02 1.45 1.46 0.01
1.56 1.48 0.08 1.56 1.52 0.04
1.60 1.55 0.05 1.60 1.63 0.03
ON
H
N
Aliphatic Chain
[Antibacterial Activity]
Aromatic Nucleus
[Antifungal Activity]
Cl at ortho position
[Antimicrobial activity]
NO
2
[Antifungal activity]
Fig. 1. Structural requirements for the antimicrobial activity benzylidene/2-chlor-
obenzylidene hydrazides.
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pMICf ¼ 0:3593cþ 1:251 (8)
n ¼ 20 r ¼ 0:591 q2 ¼ 0:120 s ¼ 0:185 F ¼ 9:66
The mt-QSAR model of antimicrobial activity (Eq. (9)) depicted
the importance of second order molecular connectivity index (2c)
in describing the antimicrobial activity of synthesized substituted
benzylidene hydrazide derivatives.
mt-QSAR model for antimicrobial activity
pMICam ¼ 0:0512cþ 1:024 (9)
n ¼ 20 r ¼ 0:609 q2 ¼ 0:278 s ¼ 0:87 F ¼ 10:63
pMICam ¼ 0:0742c 0:010ka3 þ 0:909 (10)
n ¼ 20 r ¼ 0:719 q2 ¼ 0:315 s ¼ 0:079 F ¼ 9:08
Further, in case of mt-QSAR model for antimicrobial activity
higher regression coefficient was obtained when we go for
multiple linear regression analysis. In multiple linear regression
(MLR) analysis, the coefficient of regression (r) increases to
0.719 from 0.609 (in linear regression), thus leading to an
increase in predictability of mt-QSAR models, which can be
observed by the low residual values (Table 9). It was observed
from mt-QSAR models (Eqs. (6)e(10)) that the antibacterial,
antifungal and overall antimicrobial activity of synthesized
substituted benzylidene hydrazides is governed by second order
molecular connectivity index (2c) and third order Kier’s alpha
shape index (ka3).3.3. Structure activity relationship
From the results of antimicrobial activity, the following struc-
ture activity relationship can be drawn:Table 10
Cytotoxicity and antiviral activity of synthesized benzylidene hydrazides in HeLa cell cul
Comp. Cytotoxicity (mg/mL) Antiviral EC50c (mg/
CC50a Minimum cytotoxic conc.b Vesicular stomatiti
Visual CPE score
9 61.2 100 9
19 64.0 100 12
DS-5000 >100 >100 >100
(S)-DHPA (mM) >250 >250 >250
Ribavirin (mM) >250 >250 25
a 50% Cytotoxic concentration, as determined by measuring the cell viability with the
b Minimum compound concentration that causes a microscopically detectable alterati
c 50% Effective concentration, or concentration producing 50% inhibition of virus-induc
cell viability with the colorimetric formazan-based MTS assay.1. The compounds have shown marked antifungal potential as
compared to antibacterial activity, which shows that different
structural requirements are essential for antibacterial
and antifungal activity. These results are similar to Sortino
et al. [48].
2. The synthesized compounds derived from o-chlor-
obenzaldehyde have shown higher activity as compared to
those derived from benzaldehyde. This observation reveals the
fact that presence of chloro substituent at ortho position
increases the antibacterial and antifungal potential of the
compounds. This fact is supported by the observations of
Guven et al. [49].
3. It can also be seen from the results of antibacterial and anti-
fungal activity that the activity increases with increase in chain
length of acid portion of synthesized compounds (1e4, 11e14).
This is similar to one of our previous reports [23].
4. Compounds 6 and 16 derived from cinnamic acid have shown
better activity as compared to other synthesized compounds.
This may be due to the presence of extended conjugation in
cinnamic acid portion and aromatic nucleus of aldehydes,
which may be involved in binding of synthesized compound
with the target site. This fact is supported by one of our earlier
studies [24].
5. The presence of electron withdrawing group (NO2) in
compounds 10 and 20 makes them highly active antibacterial
and antifungal agents. The role of electron withdrawing group
in increasing the antibacterial and antifungal activity is similar
to the results of P. Sharma et al. [50]. The SAR results are
summarized in Fig. 1.
3.4. Antiviral activity
The antiviral screening of benzylidene/2-chlorobenzylidene
hydrazides (1e20) was performed using an MTS-based CPE
reduction assay [51] against Feline Corona virus (FIPV), Feline
Herpes virus in CRFK cell culture; Herpes simplex virus-1 (KOS)
[HSV-1 KOS], Herpes simplex virus-2 (G) [HSV-2G], Vaccinia virus
[VV], Vesicular stomatitis virus [VSV], Herpes simplex virus-1 TK
KOS ACVr [HSV-1 TK KOS ACVr] in HEL cell cultures; Vesicular
stomatitis virus (VSV), Coxsackie virus B4 [CV-B4], Respiratory
syncytial virus [RSV] in HeLa cell cultures; Influenza A virus H1N1
subtype, Influenza A virus H3N2 subtype and influenza B virus in
MDCK cell cultures; Para-influenza-3 virus [PI-3V], Reovirus-1 [RV-
1], Sindbis virus [SV], Coxsackie virus B4 [CV-B4], Punta Toro virus
[PTV] in Vero cell cultures.
None of the synthesized benzylidene hydrazide derivatives was
found to be active against the tested viral strains. The compounds 9
and 19 being exceptional have shown antiviral potential against
Vesicular stomatitis virus (VSV) in HeLa cells (Table 10). No specific
antiviral effects (MCC 5-fold higher than EC50) were noted for any
of the compounds in HEL, CRFK, MDCK and VERO cell cultures.tures.
mL)
s virus Coxsackie virus B4 Respiratory syncytial virus
MTS Visual CPE score MTS Visual CPE score MTS
6.5 >20 >20 >20 >20
13.2 >20 >20 >20 >20
>100 >100 >100 4 1.7
>250 >250 >250 >250 >250
17.2 112 73.1 10 6.6
colorimetric formazan-based MTS assay.
on of normal cell morphology.
ed cytopathic effect, as determined by visual scoring of the CPE, or by measuring the
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but they have got high cytotoxic concentration values.
4. Conclusion
A series of benzylidene hydrazides (1e20) were tested for their in
vitro antimicrobial activity against S. aureus, B. subtilis, E. coli, C. albi-
cans and A. niger. The results of antimicrobial activity indicated that
compoundshavingchloroandnitro substituentswere themostactive
ones. The results of MBC/MFC revealed that some of the compounds
viz. 13, 14 and 11e13 were bactericidal against B. subtilis and E. coli
respectively. The antiviral evaluation depicted that compounds 9 and
19 were active against Vesicular stomatitis virus (VSV) in HeLa cell
cultures. To understand the relationship between physicochemical
parameters and antibacterial and antifungal activity of substituted
benzylidene hydrazide derivatives, QSAR investigation was per-
formed by development of one-target and multi-target models. The
multi-target model was found to be effective in describing the anti-
microbial activity of substitutedhydrazides in comparison to the one-
target models. Further it indicated the importance of the topological
parameters, second ordermolecular connectivity index (2c) and third
order Kier’s alpha shape index (ka3) in describing the antimicrobial
activity of substituted hydrazides.
5. Experimental
Melting points were determined in open capillary tubes on
a sonar melting point apparatus and are uncorrected. Reaction
progress was monitored by thin layer chromatography on silica gel
sheets (Merck silica gel G) and purity of compounds was ascer-
tained by single spot on TLC sheet. 1H nuclear magnetic resonance
(1H NMR) spectra were recorded on Bruker Avance II 400 NMR
spectrometer using appropriate deuterated solvents and are
expressed in parts per million (d, ppm) downfield from tetrame-
thylsilane (internal standard). Infrared (IR) spectra were recorded
on Perkin Elmer FTIR spectrometer using KBr pellets.
5.1. General procedure for synthesis of ester
The mixture of corresponding acid (0.08 mol) and ethanol
(0.74 mol) was heated under reflux in the presence of sulphuric
acid till the completion of reaction. Then, the reaction mixture was
added to 200 mL ice cold water and the residual acid was removed
by treatment with sodium bicarbonate. The ester formed was
extracted with ether (50 mL). The ether layer was separated which
on evaporation yielded the crude ester that was recrystallized from
alcohol.
5.2. General procedure for synthesis of acid hydrazides
Hydrazine hydrate (99%) (0.015 mol) was added in ethanolic
solution of ester (0.01 mol) and refluxed for 5 h. The reaction
mixture was then cooled and the precipitates were filtered off,
washed with water, dried and recrystallized from ethanol.
5.3. General procedure for synthesis hydrazones
The solution of acid hydrazide (0.01 mol) and appropriate
aldehyde (0.01 mol) in ethanol was refluxed for 4e5 h. The
precipitates obtained were filtered off, washed with water and
recrystallized from ethanol.
5.3.1. Analytical data of compound 1
Mp (C) 60e64; Yield e 67.80%; 1H NMR (400 MHz, CDCl3)
d ppm: 0.82e0.86 (t, 3H, CH3), 1.19e2.63 (m, 20H, CH2), 7.01e7.67(m, 5H, ArH), 8.10 (s, 1H, NH). IR (KBr pellets) n cm1: 3069.79 (CH
str., aromatic), 2923.03 (CH str., aliphatic), 1616.80 (C]O str.),
1434.25 (C]C str., aromatic).
5.3.2. Analytical data of compound 5
Mp (C) Semisolid; Yield e 45.10%; 1H NMR (400 MHz, CDCl3)
d ppm: 1.32e1.38 (t, 3H, CH3), 5.72 (m,1H, CH of CHCH3), 6.20 (t, 1H,
terminal CH of CH] CHCH3), 7.43e7.45 (m, 5H, ArH), 8.67 (s, 1H,
NH). IR (KBr pellets) n cm1: 3211.03 (NH str., amide), 3028.7 (CH
str., aromatic), 2974.8 (CH str., aromatic), 1725.9 (C]O str.), 1658.5
(C]C str., aliphatic).
5.3.3. Analytical data of compound 9
Mp (C) 228e232; Yield e 74.00%; 1H NMR (400 MHz, CDCl3)
d ppm: 3.92 (s, 6H, OCH3), 6.86 (s, 1H, CH of ArOCH3), 7.27 (s, 2H, CH
of C2 and C6 of ArOCH3), 7.46e7.69 (m, 5H, ArH), 8.67 (s, 1H, NH). IR
(KBr pellets) n cm1: 3211.03 (NH str., amide), 3061.3 (CH str.,
aromatic), 2976.7 (CH str., aromatic), 1709.7 (C]O str.), 1625.5 (C]
C str., aliphatic).
5.3.4. Analytical data of compound 13
Mp (C) 98e102; Yield e 63.00%; 1H NMR (400 MHz, CDCl3)
d ppm: 0.87e0.89 (t, 3H, CH3), 1.21e1.28 (m, 28H, CH2), 7.24e7.43
(m, 3H, CH of C4, C5 and C6 of ArH), 7.65e7.67 (d, 1H, CH of C3 of
ArH), 10.45e10.47 (s, 1H, NH). IR (KBr pellets) n cm1: 3299.72 (NH
str., amide), 3039.73 (CH str., Aromatic), 2949.53 (CH str., aliphatic.),
1702.40 (C]O str.), 793.73 (CeCl str.).
5.3.5. Analytical data of compound 14
Mp (C) 108e112; Yield e 22.30%; 1H NMR (400 MHz, CDCl3)
d ppm: 1.36e1.40 (s, 3H, CH3), 4.33e4.37 (s, 1H, N]CH), 7.25e7.44
(m, 4H, ArH of AreCH3), 7.85e8.20 (m, 4H, ArH of AreCl), 9.08 (s,
1H, NH). IR (KBr pellets) n cm1: 3299.72 (NH str., amide), 3038.91
(CH str., Aromatic), 2949.74 (CH str., aliphatic), 1718.40 (C]O str.),
794.92 (CeCl str.).
5.3.6. Analytical data of compound 16
Mp (C) Semisolid; Yield e 80.20%; 1H NMR (400 MHz, CDCl3)
d ppm: 5.60e5.62 (d, 2H, CH of CH]CHeC]O), 6.35 (s, 1H, N]CH),
7.21e7.30 (m, 5H, ArH of cinnamic acid), 7.32e7.46 (m, 4H, AreCl),
9.28 (s, 1H, NH). IR (KBr pellets) n cm1: 3229.10 (NH str., amide),
3062.6 (CH str., aromatic), 2976.8 (CH str., aliphatic), 1669.4 (C]O
str.), 755.8 (CeCl str.).
5.4. Evaluation of antimicrobial activity
5.4.1. Determination of MIC
The antimicrobial activity was performed against Gram-positive
bacteria: S. aureus, B. subtilis, Gram-negative bacterium: E. coli and
fungal strains: C. albicans and A. niger. The standard and test
sampleswere dissolved inDMSO to give a concentration of 100 mg/mL.
The minimum inhibitory concentration (MIC) was determined by
tube dilution method [27]. Dilutions of test and standard
compounds were prepared in double strength nutrient broth e I.P.
(bacteria) or Sabouraud dextrose broth I.P. [52] (fungi). The samples
were incubated at 37 C for 24 h (bacteria), at 25 C for 7 days
(A. niger) and at 37 C for 48 h (C. albicans), respectively, and the
results were recorded in terms of MIC (the lowest concentration of
test substance which inhibited the growth of microorganisms).
5.4.2. Determination of MBC/MFC
The minimum bactericidal concentration (MBC) and fungicidal
concentration (MFC) were determined by subculturing on fresh
medium 100 mL of culture from each tube that remained clear in the
MIC determination. MBC and MFC values represent the lowest
D. Kumar et al. / European Journal of Medicinal Chemistry 45 (2010) 2806e2816 2815concentration of compound that produces a 99.9% end point
reduction [53].
5.5. QSAR studies
The details of molecular descriptors are available in literature
and therefore they are not discussed over here [29e34]. The
structures of benzylidene hydrazide derivatives are first pre-opti-
mized with the Molecular Mechanics Force Field (MMþ) procedure
included in Hyperchem 6.03 [54] and the resulting geometries are
further refined by means of the semiempirical method PM3
(parametric Method-3). We chose a gradient norm limit of
0.01 kcal/A for the geometry optimization. The lowest energy
structure was used for each molecule to calculate physicochemical
properties using TSAR 3.3 software for Windows [55]. Further, the
regression analysis was performed using the SPSS software package
[56]. The predictive powers of the equation were validated by
determination of cross-validated r2 (q2) using leave one out (LOO)
cross-validation method [57].
5.6. Evaluation of antiviral activity
5.6.1. Antiviral assay
The antiviral screening of benzylidene/2-chlorobenzylidene
hydrazides (1e20) was performed against Feline Corona virus
(FIPV), Feline Herpes virus in CRFK cell culture; Herpes simplex
virus-1 (KOS) [HSV-1 KOS], Herpes simplex virus-2 (G) [HSV-2G],
Vaccinia virus [VV], Vesicular stomatitis virus [VSV], Herpes
simplex virus-1 TK KOS ACVr [HSV-1 TK KOS ACVr] in HEL cell
cultures; Vesicular stomatitis virus (VSV), Coxsackie virus B4 [CV-
B4], Respiratory syncytial virus [RSV] in HeLa cell cultures; Para-
influenza-3 virus [PI-3V], Reovirus-1 [RV-1], Sindbis virus [SV],
Coxsackie virus B4 [CV-B4], Punta Toro virus [PTV] in Vero cell
cultures; Influenza A virus H1N1 subtype, Influenza A virus H3N2
subtype and influenza B virus in MDCK cell cultures and the
results were expressed as the 50% effective concentration (EC50).
Cells, grown to confluency in 96-well plates, were infected with
100 CCID50 of virus, one CCID50 being the 50% cell culture
infective dose. After an adsorption period of 2 h at 37 C, virus
was removed and serial dilutions of the compounds were added.
The cultures were further incubated at 37 C for 3 days, until
complete CPE was observed in the infected and untreated virus
control.
5.6.2. Cytotoxic assay
The cytotoxicity of the compounds was evaluated in parallel
with their antiviral activity in uninfected cells, and is expressed as
minimum cytotoxic concentration to cause a microscopically
detectable alteration of normal cell morphology (HEL cells, HeLa
cells, CRFK cells, MDCK cells and Vero cells).
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